BRUSSELS, April 9 (Reuters) - Pharmaceutical compounding group Fagron is in talks to make acquisitions in Europe, the United States and Brazil, the group's chief executive said on Thursday.
The group, which sells in ingredients to pharmacists to make bespoke medicines, announced no acquisitions in the first quarter.
Also read: Cree and Infineon Call Off Wolfspeed Deal
19:44 Shadow president or mere shadow? In Europe, Pence seeks to reassure allies unnerved by Trump8
00:02 Omar Abdel Rahman, imprisoned ‘blind sheikh’ linked to terrorist efforts, dies at 7821
11:30 Pence and Merkel embrace NATO but differ on transatlantic partnership21
12:33 U.S.' Tillerson calms allies on Syria ahead of Geneva talks15